E. Ohman J or Asset Management AB Sells 2,015 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

E. Ohman J or Asset Management AB cut its stake in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 4.8% in the first quarter, Holdings Channel reports. The fund owned 39,955 shares of the healthcare conglomerate’s stock after selling 2,015 shares during the period. E. Ohman J or Asset Management AB’s holdings in UnitedHealth Group were worth $20,926,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in UNH. Financial Management Professionals Inc. increased its position in shares of UnitedHealth Group by 0.8% during the 1st quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate’s stock valued at $1,165,000 after purchasing an additional 17 shares during the last quarter. Richwood Investment Advisors LLC increased its position in shares of UnitedHealth Group by 0.4% during the 4th quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate’s stock valued at $2,654,000 after purchasing an additional 20 shares during the last quarter. Global Wealth Strategies & Associates increased its position in shares of UnitedHealth Group by 28.6% during the 1st quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate’s stock valued at $47,000 after purchasing an additional 20 shares during the last quarter. Prentice Wealth Management LLC increased its position in shares of UnitedHealth Group by 0.8% during the 4th quarter. Prentice Wealth Management LLC now owns 2,527 shares of the healthcare conglomerate’s stock valued at $1,278,000 after purchasing an additional 21 shares during the last quarter. Finally, 44 Wealth Management LLC increased its position in shares of UnitedHealth Group by 1.6% during the 4th quarter. 44 Wealth Management LLC now owns 1,309 shares of the healthcare conglomerate’s stock valued at $662,000 after purchasing an additional 21 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

Insider Activity

In related news, CFO John F. Rex purchased 17,175 shares of the business’s stock in a transaction dated Friday, May 16th. The stock was bought at an average cost of $291.12 per share, with a total value of $4,999,986.00. Following the completion of the acquisition, the chief financial officer now directly owns 203,796 shares in the company, valued at $59,329,091.52. The trade was a 9.20% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Kristen Gil purchased 3,700 shares of the firm’s stock in a transaction on Thursday, May 15th. The shares were purchased at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the completion of the purchase, the director now directly owns 3,818 shares in the company, valued at $1,035,327.06. The trade was a 3,135.59% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last quarter, insiders purchased 109,408 shares of company stock worth $31,607,768. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Down 1.6%

Shares of UNH opened at $295.61 on Friday. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73. The stock has a market capitalization of $268.16 billion, a price-to-earnings ratio of 19.07, a PEG ratio of 1.37 and a beta of 0.56. The stock has a 50 day moving average price of $413.43 and a 200 day moving average price of $486.09. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNHGet Free Report) last announced its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same period last year, the company earned $6.91 EPS. Equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th will be issued a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a yield of 2.99%. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.10. UnitedHealth Group’s dividend payout ratio (DPR) is presently 35.18%.

Wall Street Analyst Weigh In

UNH has been the subject of several analyst reports. TD Cowen cut UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 target price for the company. in a report on Monday, May 19th. Barclays dropped their target price on UnitedHealth Group to $350.00 and set an “overweight” rating for the company in a report on Monday. Bank of America cut UnitedHealth Group from a “buy” rating to a “neutral” rating and dropped their target price for the company from $560.00 to $350.00 in a report on Wednesday, May 14th. Argus cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Monday, April 21st. Finally, Wolfe Research dropped their target price on UnitedHealth Group from $501.00 to $390.00 and set an “outperform” rating for the company in a report on Tuesday, May 20th. One analyst has rated the stock with a sell rating, seven have issued a hold rating and seventeen have given a buy rating to the company. According to MarketBeat, UnitedHealth Group currently has an average rating of “Moderate Buy” and an average target price of $428.43.

Read Our Latest Analysis on UNH

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

See Also

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.